3 Stocks That Could Make Huge Moves This Week

Prepare yourself, Fools. The three stocks I'm talking about today are primed to make some huge moves in the coming week. But instead of trying to time the market and buy or sell these stocks before the volatility arrives, I suggest you do ... nothing.

That's especially true if you're a shareholder of this week's big movers: Best Buy  (NYSE: BBY  ) , Staples  (NASDAQ: SPLS  ) , and GameStop  (NYSE: GME  ) . All three of these companies will be reporting earnings, and all three also have lots of investors shorting their stock. That's a recipe for the kind of swings you don't often see during an average market day.

While Wall Street will be focusing on short-term numbers -- like meeting one quarter's revenue and earnings expectations -- read on to see what long-term investors should really be looking for, and why so many are down on these stocks.

Will this stock be your next multibagger?
Give us five minutes and we'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks one stock with amazing potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303%! You don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.


Read/Post Comments (2) | Recommend This Article (9)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 18, 2014, at 6:38 PM, WCoastGuynCA wrote:

    Small Bio-Tech With 9,941 Followers On Twitter

    Amarantus Bioscience - AMBS - will be launching the first blood test to detect early stage Alzheimer's this year. It is developing LymPro in conjunction with Becton Dickinson. Quest Diagnostics is rumored to be the marketing partner in the U.S.: potential $500M annual market.

    The company announced last week the opening of an office in Geneva, Switzerland to pursue opportunities in the E.U.

    The company's patented drug, MANF, already has three orphan indications. One is for Retinitis Pigmentosa. One is in the field of diabetes.

    Zacks: Buy Rating

    Twitter: @AmarantusBio .... 9,941 followers.

    p.s. So much potential for less than a dime currently

  • Report this Comment On May 18, 2014, at 10:16 PM, sporked wrote:

    this information has the same relevancy as my movements

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2959653, ~/Articles/ArticleHandler.aspx, 10/20/2014 11:55:52 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement